NAFDAC approves conditional emergency use for test kits

 NAFDAC approves conditional emergency use for test kits

The National Agency for Food, Drug Administration and Control (NAFDAC) has granted conditional emergency use approval of medical devices for COVID-19 antibody, as well as antigen test kits to manufacturing companies and importers of such devices.

The test kits will help to detect the virus in COVID19 confirmed cases to confirm their immunity against the virus it also can be used to detect COVID-19 antigen in patients with or without symptoms

What led to NAFDAC’s decision?

Director-General of NAFDAC, Professor Mojisola Adeyeye, who disclosed this in Abuja, noted that the COVID-19 pandemic necessitated that the agency put measures in place to ensure access to health commodities that have the potential to impact positively on public health outcomes.

NAFDAC did not approve the use of Vaccines and has said that certain guidelines are needed to be followed, to ensure safety and efficacy.

Guidelines and policies to be followed are clinical testings and in-country assessment which takes about 2 years and 6 months.

Academies seek international co-operation

In a related development, the G-Science Academies of Science and Medicine from across the globe, including academies of the G-7 countries have advocated greater international cooperation to contain coronavirus.

Among other demands, they canvassed rapid, accurate and transparent international communication about the unfolding epidemiology of the disease, including patterns of transmission, incubation period, its lethal nature and the efficiency of the various intervention methods.

The 15 Academies of Sciences and Medicine made the clarification in a joint statement issued by Executive Secretary, Nigerian Academy of Science (NAS) and Chair, INGSA-Africa (Science Academies in Africa), Dr. M. Oladoyin Odubanjo.